Skip to main content

Quantum Biopharma Ltd.

corporate_fare Company Profile

Quantum Biopharma Ltd.

QNTM·NASDAQ·Life Sciences·CIK 0001771885

Quantum Biopharma Ltd. is a biopharmaceutical company that operates through two segments: Biopharmaceutical Innovation and Strategic Investments. The company focuses on researching and developing a portfolio of assets and biotech solutions for neurodegenerative, inflammatory, metabolic, and alcohol misuse disorders, with drug candidates at various development stages. Its lead compound, Lucid-MS, is a patented new chemical entity currently in a Phase 2 clinical trial. Lucid-MS aims to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, as demonstrated in preclinical models. Quantum Biopharma Ltd. also develops FSD-PEA, which is preparing for a Phase 2 trial for inflammatory diseases like mast cell activation syndrome. Other developments include Lucid-PSYCH for major depressive disorder and unbuzzd, a dietary supplement for alcohol misuse. The Strategic Investments segment includes a portfolio of loans secured by residential property. The company, founded in 1998, changed its name from FSD Pharma Inc. to Quantum Biopharma Ltd. in August 2024 and is based in Toronto, Canada.

Quantum Biopharma Ltd. (NASDAQ:QNTM) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 27 items for QNTM at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-12, rated 7/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 9 rated 8 or above. Recent SEC coverage for QNTM spans 6-K.

Recent high-impact activity:

  • Quantum BioPharma Posts $17.3M Nine-Month Loss; Cash Rises to $3.56M on ATM and Debenture Funding
  • Quantum BioPharma Insiders Lift Voting Control to 68% Via C$80.86 MVS Placement; Reverse-Split Authority Approved
  • Quantum BioPharma's Market Manipulation Lawsuit Consolidated; Grant & Eisenhofer Named Lead Counsel
  • Quantum BioPharma Taps Thermo Fisher's PPD to Run Phase 2 Lucid-MS Trial
  • Quantum BioPharma Moves to Voluntarily Delist from Canadian Securities Exchange

Short Interest & Short Volume

4.52 days to cover

FINRA reported short interest of 440,005 shares in QNTM as of the October 30, 2026 settlement, a 15.4% decrease from the prior period — about 4.5 days to cover at its recent average daily volume. On November 20, 2026, 35.1% of QNTM volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)440,005 shares as of October 30, 2026
Change vs prior period▼ 15.4%
Days to cover4.52 at avg daily volume of 97,396
Daily short volume (FINRA facilities)35.1% of 76,575 shares on November 20, 2026
5-day average short volume44.2%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Insider Transactions

QNTM files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.

Browse all tickers starting with Q →
$1.29
52-week range · as of 2026-11-12 $1.29 – $12.42
Market cap
$11.3M
Volume
140.3K (1.3× avg)
3-mo avg 109.3K
Live data · 2026-11-21 20:40 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed QNTM - Latest Insights

QNTM
Nov 12, 2026, 4:06 PM EST
Filing Type: 6-K
Importance Score:
7
Price at Filing: $1.78
Real-time Price: $1.29 info
Change: -$0.490 (-28%) info
Market Cap: $11.304M info
QNTM
Nov 12, 2026, 7:00 AM EST
Filing Type: 6-K
Importance Score:
7
Price at Filing: $2.00
Real-time Price: $1.29 info
Change: -$0.710 (-36%) info
Market Cap: $11.304M info
QNTM
Oct 08, 2026, 8:00 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $3.09
Real-time Price: $1.29 info
Change: -$1.80 (-58%) info
Market Cap: $11.304M info
QNTM
Oct 06, 2026, 6:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $3.27
Real-time Price: $1.29 info
Change: -$1.98 (-61%) info
Market Cap: $11.304M info
QNTM
Sep 01, 2026, 8:28 PM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $3.02
Real-time Price: $1.29 info
Change: -$1.73 (-57%) info
Market Cap: $11.304M info
QNTM
Aug 14, 2026, 7:00 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $3.48
Real-time Price: $1.29 info
Change: -$2.19 (-63%) info
Market Cap: $11.304M info
QNTM
Aug 14, 2026, 7:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $3.49
Real-time Price: $1.29 info
Change: -$2.20 (-63%) info
Market Cap: $11.304M info
QNTM
Aug 13, 2026, 4:06 PM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $3.25
Real-time Price: $1.29 info
Change: -$1.96 (-60%) info
Market Cap: $11.304M info
QNTM
Aug 10, 2026, 12:09 PM EDT
Source: FinanceWire
Importance Score:
8
Price at Filing: $3.64
Real-time Price: $1.29 info
Change: -$2.35 (-65%) info
Market Cap: $11.304M info
QNTM
Aug 10, 2026, 7:00 AM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $3.16
Real-time Price: $1.29 info
Change: -$1.87 (-59%) info
Market Cap: $11.304M info
QNTM
Aug 03, 2026, 1:15 PM EDT
Source: FinanceWire
Importance Score:
7
Price at Filing: $2.93
Real-time Price: $1.29 info
Change: -$1.64 (-56%) info
Market Cap: $11.304M info
QNTM
Jun 02, 2026, 11:50 AM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $4.97
Real-time Price: $1.29 info
Change: -$3.68 (-74%) info
Market Cap: $11.304M info
QNTM
Jun 02, 2026, 7:40 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $5.25
Real-time Price: $1.29 info
Change: -$3.96 (-75%) info
Market Cap: $11.304M info
QNTM
May 18, 2026, 3:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $6.71
Real-time Price: $1.29 info
Change: -$5.42 (-81%) info
Market Cap: $11.304M info
QNTM
May 07, 2026, 7:00 AM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $5.11
Real-time Price: $1.29 info
Change: -$3.82 (-75%) info
Market Cap: $11.304M info
QNTM
May 06, 2026, 4:14 PM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $5.28
Real-time Price: $1.29 info
Change: -$3.99 (-76%) info
Market Cap: $11.304M info
QNTM
Apr 22, 2026, 9:31 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $3.59
Real-time Price: $1.29 info
Change: -$2.30 (-64%) info
Market Cap: $11.304M info
QNTM
Apr 02, 2026, 8:30 AM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $4.40
Real-time Price: $1.29 info
Change: -$3.11 (-71%) info
Market Cap: $11.304M info
QNTM
Apr 01, 2026, 8:02 AM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $5.18
Real-time Price: $1.29 info
Change: -$3.89 (-75%) info
Market Cap: $11.304M info
QNTM
Mar 30, 2026, 7:50 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $5.09
Real-time Price: $1.29 info
Change: -$3.80 (-75%) info
Market Cap: $11.304M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets